  
- 积分
- 13286
- 威望
- 13286
- 包包
- 34831
|
STEM CELLS Translational Medicine (SCTM) ——
# l1 d8 }. i( q, j4 ~5 @ 基于干细胞的组织工程与再生医学即将于今年年底迎来第一份转化医学专业期刊。3 ~2 n& o& }* I! f" \9 k5 w1 V
Durham, NC (Vocus/PRWEB) , April 07, 2011 ; L9 z. c* W3 d; v
3 M6 |0 M9 n; O( Z: J% q! O9 A
AlphaMed Press announces the launch of a major peer-reviewed journal, STEM CELLS Transla-
$ r, u! [9 q4 ]tional Medicine (SCTM), answering an acknowledged need within the research and clinical com-7 E0 Z$ J2 F' I B$ R* l
munities for comprehensive coverage of stem cell science, stem cell-based regenerative medi-% X& C) |' O9 _8 P+ R
cine and tissue engineering, stem cell-based predictive toxicology, and cancer stem cell investi-8 c9 p/ M6 {% K
gation.
9 v8 s, C" V; @6 d+ RSTEM CELLS Translational Medicine will publish high-impact, peer-reviewed articles that will sig-4 A6 F1 P% A8 D6 G4 v+ t
nificantly advance the clinical utilization of stem cell molecular and cellular biology by bridging
0 r1 y- Y' H8 X8 xstem cell research and clinical trials. In addition to original manuscripts, case studies, and com-$ w# I( |5 l4 M0 H5 }( l# _% u
mentaries this unique journal will encourage researchers to submit data from their negative clinical trials for publication to rapidly share results that other researchers may find valuable.
: o2 R* R6 K/ Z5 J' z1 k6 M+ `3 sThe potential of stem cells therapies and regenerative medicine is both provocative and unique, offering the distinct possibility of eventually repairing or replacing tissues damaged from disease, including certain cancers. Under the leadership of the esteemed scientist-clinician Anthony Atala, MD as Editor, STEM CELLS Translational Medicine will speed expertly executed translations of emerging lab discoveries into noteworthy clinical trials.
B3 A4 b, L) C
- X! Q0 W8 k. V0 w5 I; q"This exciting new journal will foster the proper growth and ethical development in this fast-1 W. r, z8 n8 S& n4 Y( X
moving field. There is a gap in the existing stem cells journal spectrum that STEM CELLS Trans$ ]0 P) L; u, ^
lational Medicine will fill," said Dr. Atala. "SCTM is the sister journal to STEM CELLS, the thirty-
) K+ P) b* l3 h1 Y# n: p6 w; X2 Dyear-old premier journal in the field, and together they will elevate our science to applications that will impact the lives of many patients."
' Y; {6 x6 T( z5 v4 A1 {The California Institute for Regenerative Medicine (CIRM) has provided a 3-year seed grant in
, m$ ~! t4 G$ v; o% w1 dsupport of the publication of SCTM. 2 c9 o- l( e0 z" M$ E
"Science moves forward through publications in outstanding, peer-reviewed journals," said Dr. Alan Trounson, CIRM President. : r7 f% L- y% O* P a+ r' I" n
"This new journal will provide a venue for studies that move stem cell research closer toward ! H, U3 s% N) A! C+ [
clinical trials. In addition to publishing new discoveries that help all scientists in their goals the ; n. K2 C- i/ B5 u }: l
journal will also take the unusual step of publishing studies considered "negative," with results
7 t, ?" ?7 ~/ m( ?* `) V, hthat did not back up the original hypothesis or that did not show a new path to therapies, which will save other scientists the time of carrying out those experiments."
: r- T6 A4 D: U7 `! `8 r+ }+ EIn addition, the journal will launch a multi-media platform, allowing for the production of series of online podcasts that focus on methods or clinical processes and feature key opinion leaders and thought-provoking roundtables to highlight important issues or feature premier stem cells institutes and laboratories. 4 l8 n4 `* e" z
SCTM will be available in December 2011. |
-
总评分: 威望 + 5
包包 + 10
查看全部评分
|